Marit Health | $3,200,000 | (Apr 1, 2025)
Inspiren | $35,000,000 | (Apr 1, 2025)
BetterFleet | $15,000,000 | (Apr 1, 2025)
Certified by Founder
Lodge
Carmot Therapeutics, Inc.
start up
United States
- Berkeley
- 26/07/2022
- Series D
- $160,000,000
Carmot Therapeutics, Inc. is a clinical-stage company dedicated to the discovery and development of innovative medicines. Carmot applies a transformative, patented drug discovery approach, Chemotype Evolution to explore novel frontiers of chemistry and biology. Using Chemotype Evolution, Carmot has developed a portfolio of drug candidates in metabolic disease and oncology.
- Industry Biotechnology Research
- Website https://carmot-therapeutics.us/contact-us/
- LinkedIn https://www.linkedin.com/company/carmot-therapeutics-inc/
Isomorphic Labs | $600,000,000 | (Apr 1, 2025)
Sohar Health (YC S23) | $3,800,000 | (Apr 1, 2025)
Retym, Inc | $75,000,000 | (Apr 1, 2025)
Ribbon | $8,000,000 | (Apr 1, 2025)
DeepIP | $15,000,000 | (Apr 1, 2025)
Kay.ai | $3,000,000 | (Apr 1, 2025)
GridPoint | $45,000,000 | (Apr 1, 2025)
POCKLA | $1,728,856 | (Apr 1, 2025)
mo:re | $2,485,277 | (Apr 1, 2025)